Shipping details should be treated as logistics information, not a reason to change the prescribed medicine form or strength
So far, GLP-1 injections have been the most effective option for weight loss
Does the patient have diabetes, kidney disease, gallbladder history, gastrointestinal disease, or another relevant condition
They determined that those prescribed GLP-1 agonists exhibit a significantly lower risk of developing RVO over five years, particularly for branch RVO (BRVO), compared to those on DPP-4 inhibitors, which could contribute to favorable long-term ocular outcomes and reduce the burden of visual impairment with this treatment option in this population
Water weight shifts much, much faster than fat weight, he explained